Correlation Between Nuvalent and Edgewise Therapeutics
Can any of the company-specific risk be diversified away by investing in both Nuvalent and Edgewise Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nuvalent and Edgewise Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nuvalent and Edgewise Therapeutics, you can compare the effects of market volatilities on Nuvalent and Edgewise Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nuvalent with a short position of Edgewise Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nuvalent and Edgewise Therapeutics.
Diversification Opportunities for Nuvalent and Edgewise Therapeutics
0.73 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Nuvalent and Edgewise is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding Nuvalent and Edgewise Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Edgewise Therapeutics and Nuvalent is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nuvalent are associated (or correlated) with Edgewise Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Edgewise Therapeutics has no effect on the direction of Nuvalent i.e., Nuvalent and Edgewise Therapeutics go up and down completely randomly.
Pair Corralation between Nuvalent and Edgewise Therapeutics
Given the investment horizon of 90 days Nuvalent is expected to generate 1.63 times less return on investment than Edgewise Therapeutics. But when comparing it to its historical volatility, Nuvalent is 1.47 times less risky than Edgewise Therapeutics. It trades about 0.07 of its potential returns per unit of risk. Edgewise Therapeutics is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest 678.00 in Edgewise Therapeutics on December 12, 2024 and sell it today you would earn a total of 1,978 from holding Edgewise Therapeutics or generate 291.74% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 99.8% |
| Values | Daily Returns |
Nuvalent vs. Edgewise Therapeutics
Performance |
| Timeline |
| Nuvalent |
| Edgewise Therapeutics |
Nuvalent and Edgewise Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Nuvalent and Edgewise Therapeutics
The main advantage of trading using opposite Nuvalent and Edgewise Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nuvalent position performs unexpectedly, Edgewise Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edgewise Therapeutics will offset losses from the drop in Edgewise Therapeutics' long position.| Nuvalent vs. Arcellx | ||
| Nuvalent vs. Vaxcyte | ||
| Nuvalent vs. Viridian Therapeutics | ||
| Nuvalent vs. Ventyx Biosciences |
| Edgewise Therapeutics vs. Century Therapeutics | ||
| Edgewise Therapeutics vs. C4 Therapeutics | ||
| Edgewise Therapeutics vs. Mineralys Therapeutics, Common | ||
| Edgewise Therapeutics vs. Cullinan Oncology LLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |